List of Excipients in API lisdexamfetamine dimesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lisdexamfetamine dimesylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | VYVANSE | lisdexamfetamine dimesylate | 54868-5916 | CELLULOSE, MICROCRYSTALLINE | |
| Physicians Total Care Inc | VYVANSE | lisdexamfetamine dimesylate | 54868-5916 | CROSCARMELLOSE SODIUM | |
| Physicians Total Care Inc | VYVANSE | lisdexamfetamine dimesylate | 54868-5916 | D&C RED NO. 28 | |
| Physicians Total Care Inc | VYVANSE | lisdexamfetamine dimesylate | 54868-5916 | D&C YELLOW NO. 10 | |
| Physicians Total Care Inc | VYVANSE | lisdexamfetamine dimesylate | 54868-5916 | FD&C BLUE NO. 1 | |
| Physicians Total Care Inc | VYVANSE | lisdexamfetamine dimesylate | 54868-5916 | FD&C GREEN NO. 3 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lisdexamfetamine dimesylate
Detailed excipient profiles for lisdexamfetamine dimesylate
Excipient focus: ALCOHOL
lisdexamfetamine dimesylate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | lisdexamfetamine dimesylate | 0406-5111 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing ALCOHOL
Excipient focus: AMMONIA
lisdexamfetamine dimesylate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0660 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-306 |
| Apotex Corp | lisdexamfetamine dimesylate | 60505-4739 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
lisdexamfetamine dimesylate drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BUTYL ALCOHOL
lisdexamfetamine dimesylate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0660 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM PHOSPHATE
lisdexamfetamine dimesylate drug variants containing CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0660 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing CALCIUM PHOSPHATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lisdexamfetamine dimesylate drug variants containing CELLULOSE, MICROCRYSTALLINE
lisdexamfetamine dimesylate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| Rhodes Pharmaceuticals | lisdexamfetamine dimesylate | 42858-161 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN SYRUP
lisdexamfetamine dimesylate drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing CORN SYRUP
Excipient focus: CROSCARMELLOSE SODIUM
lisdexamfetamine dimesylate drug variants containing CROSCARMELLOSE SODIUM
lisdexamfetamine dimesylate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0660 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
lisdexamfetamine dimesylate drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | lisdexamfetamine dimesylate | 42858-161 |
| Physicians Total Care Inc | lisdexamfetamine dimesylate | 54868-5916 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
lisdexamfetamine dimesylate drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| Physicians Total Care Inc | lisdexamfetamine dimesylate | 54868-5916 |
| Bryant Ranch Prepack | lisdexamfetamine dimesylate | 72162-2216 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
lisdexamfetamine dimesylate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| Solco Healthcare USLLC | lisdexamfetamine dimesylate capsules | 43547-602 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1
lisdexamfetamine dimesylate drug variants containing FD&C BLUE NO. 1
lisdexamfetamine dimesylate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
lisdexamfetamine dimesylate drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE
lisdexamfetamine dimesylate drug variants containing FD&C BLUE NO. 1--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare USLLC | lisdexamfetamine dimesylate capsules | 43547-602 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing FD&C BLUE NO. 1--ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
lisdexamfetamine dimesylate drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| Solco Healthcare USLLC | lisdexamfetamine dimesylate capsules | 43547-602 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C GREEN NO. 3
lisdexamfetamine dimesylate drug variants containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | lisdexamfetamine dimesylate | 54868-5916 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 3
lisdexamfetamine dimesylate drug variants containing FD&C RED NO. 3
lisdexamfetamine dimesylate drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
lisdexamfetamine dimesylate drug variants containing FD&C RED NO. 40
lisdexamfetamine dimesylate drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
lisdexamfetamine dimesylate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | lisdexamfetamine dimesylate | 54868-5916 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE YELLOW
lisdexamfetamine dimesylate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Physicians Total Care Inc | lisdexamfetamine dimesylate | 54868-5916 |
| Sun Pharmaceutical Industries Inc | lisdexamfetamine dimesylate | 57664-047 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
lisdexamfetamine dimesylate drug variants containing FERROSOFERRIC OXIDE
lisdexamfetamine dimesylate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
lisdexamfetamine dimesylate drug variants containing GELATIN
lisdexamfetamine dimesylate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| Novadoz Pharmaceuticals LLC | lisdexamfetamine dimesylate | 72205-132 |
| >Company | >Ingredient | >NDC |
Excipient focus: GUAR GUM
lisdexamfetamine dimesylate drug variants containing GUAR GUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| Novadoz Pharmaceuticals LLC | lisdexamfetamine dimesylate | 72205-132 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing GUAR GUM
Excipient focus: ISOPROPYL ALCOHOL
lisdexamfetamine dimesylate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0660 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
lisdexamfetamine dimesylate drug variants containing MAGNESIUM STEARATE
lisdexamfetamine dimesylate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
lisdexamfetamine dimesylate drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
lisdexamfetamine dimesylate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| Novadoz Pharmaceuticals LLC | lisdexamfetamine dimesylate | 72205-132 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing MANNITOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
lisdexamfetamine dimesylate drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
lisdexamfetamine dimesylate drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| Rhodes Pharmaceuticals | lisdexamfetamine dimesylate | 42858-161 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 302
lisdexamfetamine dimesylate drug variants containing MICROCRYSTALLINE CELLULOSE 302
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | lisdexamfetamine dimesylate | 0527-4661 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing MICROCRYSTALLINE CELLULOSE 302
Excipient focus: POTASSIUM HYDROXIDE
lisdexamfetamine dimesylate drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | lisdexamfetamine dimesylate | 42858-161 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-306 |
| Apotex Corp | lisdexamfetamine dimesylate | 60505-4739 |
| Solco Healthcare USLLC | lisdexamfetamine dimesylate capsules | 43547-602 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
lisdexamfetamine dimesylate drug variants containing PROPYLENE GLYCOL
lisdexamfetamine dimesylate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLENE GLYCOL 1,2-DISTEARATE
lisdexamfetamine dimesylate drug variants containing PROPYLENE GLYCOL 1,2-DISTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | lisdexamfetamine dimesylate | 60505-4739 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing PROPYLENE GLYCOL 1,2-DISTEARATE
Excipient focus: SHELLAC
lisdexamfetamine dimesylate drug variants containing SHELLAC
lisdexamfetamine dimesylate drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
lisdexamfetamine dimesylate drug variants containing SILICON DIOXIDE
lisdexamfetamine dimesylate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
lisdexamfetamine dimesylate drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM LAURYL SULFATE
lisdexamfetamine dimesylate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | lisdexamfetamine dimesylate | 0406-5111 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-306 |
| Solco Healthcare USLLC | lisdexamfetamine dimesylate capsules | 43547-602 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
lisdexamfetamine dimesylate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0370 |
| Hikma Pharmaceuticals USA Inc | lisdexamfetamine dimesylate | 0054-0660 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
lisdexamfetamine dimesylate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing STARCH, CORN
Excipient focus: STARCH, TAPIOCA
lisdexamfetamine dimesylate drug variants containing STARCH, TAPIOCA
| Company | Ingredient | NDC |
|---|---|---|
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing STARCH, TAPIOCA
Excipient focus: SUCRALOSE
lisdexamfetamine dimesylate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| Novadoz Pharmaceuticals LLC | lisdexamfetamine dimesylate | 72205-132 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing SUCRALOSE
Excipient focus: TARTARIC ACID
lisdexamfetamine dimesylate drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing TARTARIC ACID
Excipient focus: TITANIUM DIOXIDE
lisdexamfetamine dimesylate drug variants containing TITANIUM DIOXIDE
lisdexamfetamine dimesylate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lisdexamfetamine dimesylate | 0480-9737 |
| Ascent Pharmaceuticals Inc | lisdexamfetamine dimesylate | 43602-551 |
| Novadoz Pharmaceuticals LLC | lisdexamfetamine dimesylate | 72205-132 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
lisdexamfetamine dimesylate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | lisdexamfetamine dimesylate | 0406-5111 |
| >Company | >Ingredient | >NDC |
lisdexamfetamine dimesylate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
